Content about Nicotine

July 22, 2011

Perrigo on Thursday announced that it has received approval from the Food and Drug Administration to market a cinnamon-flavored, over-the-counter coated nicotine polacrilex gum USP in 2-mg and 4-mg strengths.

ALLEGAN, Mich. — Perrigo on Thursday announced that it has received approval from the Food and Drug Administration to market a cinnamon-flavored, over-the-counter coated nicotine polacrilex gum USP in 2-mg and 4-mg strengths.

The product will be marketed under store-brand labels and is comparable with GlaxoSmithKline's Nicorette Cinnamon Surge coated gum, a stop-smoking aid.

March 24, 2011

Four-in-5 menthol smokers would quit if the Food and Drug Administration banned mentholated cigarettes, according to a survey conducted this month with sponsorship from GlaxoSmithKline Consumer Healthcare.

PARSIPPANY, N.J. — Four-in-5 menthol smokers would quit if the Food and Drug Administration banned mentholated cigarettes, according to a survey conducted this month with sponsorship from GlaxoSmithKline Consumer Healthcare.

The survey found that smokers of menthol cigarettes — who are disproportionately African-American — feel “twice-addicted” to the menthol and the tobacco, while 74% of them said the menthol made inhalation easier, and 40% said menthol flavoring was the only reason they smoked.

February 14, 2011

The Pennsylvania Department of Health on Friday announced it would be distributing free nicotine replacement therapy kits beginning on Valentine's Day, Feb. 14, to help Pennsylvanians who want to give up tobacco “in the name of love.”

HARRISBURG, Pa. — The Pennsylvania Department of Health on Friday announced it would be distributing free nicotine replacement therapy kits beginning on Valentine's Day, Feb. 14, to help Pennsylvanians who want to give up tobacco “in the name of love.”

Under the Quit for Love campaign, the kits will be available through the state's Free Quitline (1-800-QUIT-NOW) for approximately six to eight weeks, or while supplies last.

December 7, 2010

PARSIPPANY, N.J. — The Food and Drug Administration is exploring the benefits associated with the long-term use of nicotine-replacement therapy products, a factor expected to both extend the amount of time a person avails themselves of the smoking-cessation therapy, as well as increase the success rates for quit attempts. 


October 27, 2010

GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific...

PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific workshop this week that focused on the risks and benefits associated with the long-term use of nicotine-replacement therapy products.

 

September 27, 2010

GlaxoSmithKline Consumer Healthcare is urging the Food and Drug Administration to remove smokeless tobacco products...

PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare is urging the Food and Drug Administration to remove smokeless tobacco products from the market.

April 26, 2010

GlaxoSmithKline announced Tuesday the launch of its new Nicorette Mini Lozenge, a smaller smoking-cessation lozenge...

PARSIPPANY, N.J. GlaxoSmithKline announced Tuesday the launch of its new Nicorette Mini Lozenge, a smaller smoking-cessation lozenge that dissolves three times faster than stop-smoking lozenges currently on the market. The lozenges will be lined-priced with existing smoking-cessation products and will be sold at U.S. retail healthcare centers as three small vials, each containing 27 lozenges.

March 4, 2010

Electronic cigarettes now are used by 1-in-4 smokers, claimed E Cigarettes National on Thursday, in...

February 28, 2010

Future ex-smokers who use a nicotinepatch therapy longer than currently recommended may be less likely...

February 22, 2010

Despite the ongoing battle between the Food and Drug Administration and electronic cigarette makers, one...

February 1, 2010

Future ex-smokers who utilize a nicotine-patch therapy longer may be less likely to relapse, according...